Supplemental material
Journal of Market Access & Health Policy
Volume 5, 2017 - Issue 1
Open access
2,165
Views
27
CrossRef citations to date
0
Altmetric
Original Research Article
Filling the gap in CNS drug development: evaluation of the role of drug repurposing
A. CabanCreativ-Ceutical, Pricing & Market Access Department, Krakow, PolandCorrespondence[email protected]
, K. PisarczykCreativ-Ceutical, Pricing & Market Access Department, Krakow, Poland
, K. KopaczCreativ-Ceutical, Pricing & Market Access Department, Krakow, Poland
, A. KapuśniakCreativ-Ceutical, Pricing & Market Access Department, Krakow, Poland
, M. ToumiFaculté de Médecine, Laboratoire de Santé Publique, Aix-Marseille Université, Université de la Méditerranée, Marseille Cedex, France
http://orcid.org/0000-0001-7939-7204
C. RémuzatCreativ-Ceutical, Pricing & Market Access Department, Paris, France
& A. KornfeldCreativ-Ceutical, Pricing & Market Access Department, Paris, France
show all
Article: 1299833
|
Received 24 Jan 2017, Accepted 15 Feb 2017, Published online: 10 Apr 2017
Related Research Data
Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review.
Source:
Frontiers Media S.A.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.